E-LIB Suche - Ergebnisse für: Assoumou, L.

1

Perception of PrEP‐related stigma in PrEP users: Results fr..:

Protiere, C. ; Sagaon‐Teyssier, L. ; Donadille, C....
HIV Medicine. 24 (2023) 8 - p. 938-945 , 2023

Link: https://doi.org/10.1111/..

2

EE485 Cost-Effectiveness of a 4 Days-a-Week Triple Therapy ..:

Hejblum, G. ; Daher, S. ; Moulaire, P....
Value in Health. 26 (2023) 12 - p. S144-S145 , 2023

Link: https://doi.org/10.1016/..

3

Prevalence and factors associated with symptom persistence:..:

Faycal, A. ; Ndoadoumgue, A.L. ; Sellem, B....
Infectious Diseases Now. 52 (2022) 2 - p. 75-81 , 2022

Link: https://doi.org/10.1016/..

4

Olfactory and gustatory dysfunctions in COVID-19 outpatient..:

Cousyn, L. ; Sellem, B. ; Palich, R....
Infectious Diseases Now. 51 (2021) 5 - p. 440-444 , 2021

Link: https://doi.org/10.1016/..

5

Low incidence of acute rejection within 6 months of kidney ..:

Matignon, M ; Lelièvre, J‐D ; Lahiani, A...
HIV Medicine. 20 (2019) 3 - p. 202-213 , 2019

Link: https://doi.org/10.1111/..

6

Long-term follow-up of HIV-infected patients on dolutegravi..:

Katlama, C ; Assoumou, L ; Marcelin, A G...
Journal of Antimicrobial Chemotherapy. 75 (2019) 3 - p. 675-680 , 2019

Link: https://doi.org/10.1093/..

7

Routine screening for HIV, hepatitis B virus and hepatitis ..:

Assoumou, L ; Thormann, F ; Soulié, C...
HIV Medicine. 20 (2019) 5 - p. 353-358 , 2019

Link: https://doi.org/10.1111/..

8

Silent Cerebral Small-Vessel Disease Is Twice as Prevalent ..:

Moulignier, Antoine ; Savatovsky, Julien ; Assoumou, Lambert...
Clinical Infectious Diseases. 66 (2017) 11 - p. 1762-1769 , 2017

Link: https://doi.org/10.1093/..

9

Prevalence of HIV-1 drug resistance in treated patients wit..:

Assoumou, L. ; Charpentier, C. ; Recordon-Pinson, P....
Journal of Antimicrobial Chemotherapy. 72 (2017) 6 - p. 1769-1773 , 2017

Link: https://doi.org/10.1093/..

10

Liver steatosis and fibrosis in at-risk European HIV-monoin..:

Lemoine, M. ; Assoumou, L. ; Ingiliz, P....
Journal of Hepatology. 66 (2017) 1 - p. S424 , 2017

Link: https://doi.org/10.1016/..

11

Risk of HIV transmission during combined ART initiation for..:

Supervie, V ; Assoumou, L ; Breban, R...
Journal of Antimicrobial Chemotherapy. 72 (2017) 11 - p. 3172-3176 , 2017

Link: https://doi.org/10.1093/..

12

Darunavir/ritonavir monotherapy at a low dose (600/100 mg/d..:

Seang, S ; Schneider, L ; Nguyen, T...
Journal of Antimicrobial Chemotherapy. 73 (2017) 2 - p. 490-493 , 2017

Link: https://doi.org/10.1093/..

13

Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi..:

Desnoyer, A. ; Dupin, N. ; Assoumou, L....
British Journal of Dermatology. 175 (2016) 6 - p. 1251-1262 , 2016

Link: https://doi.org/10.1111/..

14

Plasma concentrations of maraviroc and raltegravir after du..:

Lê, Minh Patrick ; Soulié, Cathia ; Assoumou, Lambert...
Journal of Antimicrobial Chemotherapy. 70 (2015) 8 - p. 2418-2420 , 2015

Link: https://doi.org/10.1093/..

15

Virological factors associated with outcome of dual maravir..:

Soulié, Cathia ; Assoumou, Lambert ; Darty, Mélanie...
Journal of Antimicrobial Chemotherapy. 70 (2015) 12 - p. 3339-3344 , 2015

Link: https://doi.org/10.1093/..